(VIANEWS) - Texas Capital Bancshares (TCBI), Profire Energy (PFIE), Blackstone Mortgage Trust (BXMT) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Texas Capital Bancshares (TCBI)
33.2% sales growth and 5.98% return on equity
Texas Capital Bancshares, Inc. operates as the bank holding company for Texas Capital Bank, National Association that provides various banking products and services for commercial businesses, and professionals and entrepreneurs. It offers business deposit products and services, including commercial checking accounts, lockbox accounts, and cash concentration accounts, as well as other treasury management services, including information services, wire transfer initiation, ACH initiation, account transfer, and service integration; and consumer deposit products, such as checking accounts, savings accounts, money market accounts, and certificates of deposit. The company also provides commercial loans for general corporate purposes comprising financing for working capital, internal growth, and acquisitions, as well as financing for business insurance premiums; real estate term and construction loans; mortgage warehouse lending; mortgage correspondent aggregation; equipment finance and leasing; treasury management services, including online banking and debit and credit card services; escrow services; and letters of credit. In addition, it offers personal wealth management and trust services; secured and unsecured loans; and online and mobile banking services. Further, the company provides American Airlines AAdvantage, an all-digital branch offering depositors. It operates in Austin, Fort Worth, Dallas, Houston, and San Antonio metropolitan areas of Texas. Texas Capital Bancshares, Inc. was founded in 1996 and is headquartered in Dallas, Texas.
Earnings Per Share
As for profitability, Texas Capital Bancshares has a trailing twelve months EPS of $3.14.
PE Ratio
Texas Capital Bancshares has a trailing twelve months price to earnings ratio of 17.45. Meaning, the purchaser of the share is investing $17.45 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.98%.2. Profire Energy (PFIE)
24.3% sales growth and 4.42% return on equity
Profire Energy, Inc., a technology company, provides burner, and combustion management systems and solutions for natural and forced draft applications in the United States and Canada. It primarily focuses on the upstream, midstream, and downstream transmission segments of the oil and gas industry. It also sells and installs its systems in Europe, South America, Africa, the Middle East, and Asia. The company was founded in 2002 and is based in Lindon, Utah.
Earnings per Share
Profire Energy's trailing 12 month EPS is $0.04.
PE Ratio
Profire Energy's trailing 12-month price-earnings ratio is 25.75. The purchaser of shares is required to invest $25.75 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is an indicator of the business' profitability relative to shareholders' equity, was 4.42%.Earnings before Interest, Taxes and Depreciation
Profire Energy's EBITDA stands at 1.07.
Volume
Profire Energy's current reported volume is 99520, 9.13% lower than its 109523 average volume.
3. Blackstone Mortgage Trust (BXMT)
21.9% sales growth and 9.45% return on equity
Blackstone Mortgage Trust, Inc., is a real-estate finance company that originates senior loans secured by commercial property in North America, Europe, Australia, and Europe. For federal income tax purposes, the company is a real-estate investment trust. The company is not subject to U.S. income tax if the stockholders receive at least 90% of its income taxable. The business was previously known as Capital Trust, Inc., but it changed its name in May 2013 to Blackstone Mortgage Trust, Inc. Blackstone Mortgage Trust, Inc. is located in New York, New York.
Earnings per Share
Blackstone Mortgage Trust's trailing 12-month EPS is $2.48.
PE Ratio
Blackstone Mortgage Trust's trailing 12-month price-to-earnings ratio is 9.02. The purchaser of the shares is therefore investing $9.02 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 9.45%.Revenue Growth
Year-on-year quarterly revenue growth grew by 25.5%, now sitting on 578.64M for the twelve trailing months.
Yearly Top and Bottom Value
Blackstone Mortgage Trust's stock is valued at $22.38 at 05:24 EST, way under its 52-week high of $32.91 and higher than its 52-week low of $21.49.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Dec 28, 2022, the estimated forward annual dividend rate is 2.48 and the estimated forward annual dividend yield is 11.08%.
4. Toro Company (TTC)
21.7% sales growth and 30.58% return on equity
The Toro Company is involved in designing, manufacturing and marketing professional and residential equipment around the world. Its professional segment sells turf and landscape products. This includes golf course maintenance and equipment, sports fields and grounds maintenance equipment and landscaping contractor equipment. The company also offers irrigation and lighting products. These include sprinkler heads and controllers as well as electric and hydraulic valves. Coupling systems and ag irrigation drip tape are available. Professionally installed landscape lighting products can be purchased through landscape contractors and distributors. The segment markets its products through a network distributors and dealers. It serves professionals who maintain golf courses, commercial and residential landscapes as well as rental companies and government customers. The Residential segment offers walk power and zero-turn riding lawn mowers as well as replacement parts and products for home. These include leaf and grass trimmers and blower vacuums. String trimmers and string trimmers are also available. Hose-end retail irrigation products can be found in the hose-end section. The segment is sold to homeowners via a network distributors and dealers, home centers, hardware retail stores, mass retailers and online. The Toro Company was established in 1914. It is located in Bloomington in Minnesota.
Earnings Per Share
As for profitability, Toro Company has a trailing twelve months EPS of $3.65.
PE Ratio
Toro Company has a trailing twelve months price to earnings ratio of 30.19. Meaning, the purchaser of the share is investing $30.19 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 30.58%.Growth Estimates Quarters
For the current quarter, the company expects to grow by 91.1% and 63.6 respectively.Moving Average
Toro Company's market value is much higher than the 50-day average moving price of $103.70, and far above its 200 day moving average $88.93.5. Incyte Corporation (INCY)
12.7% sales growth and 26.92% return on equity
Incyte Corporation is a biopharmaceutical firm that focuses on developing, commercializing, and distributing proprietary therapeutics throughout the United States. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia. Its clinical stage products include ruxolitinib, a steroid-refractory chronic graft-versus-host-diseases (GVHD); itacitinib, which is in Phase II/III clinical trial to treat naive chronic GVHD; and pemigatinib for treating bladder cancer, cholangiocarcinoma, myeloproliferative syndrome, and tumor agnostic. Parsaclisib is also being developed by the company. It is currently in phase II clinical trials for marginal zone lymphoma and follicular lymphoma. It also develops Retifanlimab, which is currently in Phase 2 clinical trials in MSI-high endometrial carcinoma, merkel cells carcinoma and anal carcinoma. There are collaboration agreements with Novartis International Pharmaceutical Ltd., Eli Lilly and Company, Agenus Inc., Calithera Biosciences, Inc., MacroGenics, Inc., Syros Pharmaceuticals, Inc., Syros Pharmaceuticals, Inc., Innovent Biologics, Inc., Syros Pharmaceuticals, Inc., Innovent Biologics, Inc., Zai Lab Limited, Cellenkos, Inc., and Nimble Therapeutics. These collaborations include clinical collaborations AG and tasitamab, plamotamab, lenalidomide, relapsed, plamotamab, f, f, follicular, follicular, follicular, refractory, follicular, follicular, f, follicular, follicular, refractory, and lenalidomide, and refractory, Inc. It was founded in 1991. The headquarters are in Wilmington, Delaware.
Earnings Per Share
As for profitability, Incyte Corporation has a trailing twelve months EPS of $-1.36.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 26.92%.Revenue Growth
Year-on-year quarterly revenue growth grew by 29.1%, now sitting on 3.32B for the twelve trailing months.
6. Texas Roadhouse (TXRH)
11.7% sales growth and 26.1% return on equity
Texas Roadhouse, Inc., together with its subsidiaries, operates casual dining restaurants in the United States and internationally. The company operates and franchises Texas Roadhouse and Bubba's 33 restaurants. As of December 29, 2020, it operated 537 domestic restaurants and 97 franchise restaurants. Texas Roadhouse, Inc. was founded in 1993 and is based in Louisville, Kentucky.
Earnings per Share
Texas Roadhouse's trailing 12-month EPS is $3.75.
PE Ratio
Texas Roadhouse's trailing 12-month price-to-earnings ratio is 25.78. The purchaser of the shares is investing $25.78 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 26.1%.Growth Estimates Quarters
The company's growth estimates for the current quarter and the next is 34.2% and 16.7%, respectively.Dividend Yield
Morningstar, Inc. claims that the next dividend payment will be on December 5, 2022. The forward dividend rate and yield are 1.84 and 1.9% respectively.